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mAbstract
Background: In un-resuscitated rodent models of septic shock, the peroxisome
proliferator-activated receptor-β/δ (PPAR-β/δ) agonist GW0742 improved visceral organ
function. Therefore, we tested the hypothesis whether GW0742 would attenuate kidney
injury during long-term, resuscitated, porcine polymicrobial septic shock.
Methods: Six, 12, and 18 h after the induction of fecal peritonitis by inoculation of
autologous feces, anesthetized, mechanically ventilated, and instrumented male pigs
with pre-existing atherosclerosis resulting from familial hypercholesteremia and
atherogenic diet randomly received either vehicle (dimethyl sulfoxide, n = 12) or
GW0742 (n = 10). Resuscitation comprised hydroxyethyl starch and norepinephrine
infusion titrated to maintain mean arterial pressure at baseline values.
Results: Despite aggressive fluid resuscitation, fecal peritonitis was associated with
arterial hypotension requiring norepinephrine infusion, ultimately resulting in
progressive lactic acidosis and acute kidney injury. GW0742 did not beneficially affect
any parameter of systemic and regional hemodynamics, gas exchange, metabolism, or
organ function. The parameters of inflammation, oxidative and nitrosative stress, and
organ injury (post-mortem analysis for histomorphology and markers of apoptosis)
were not influenced either. Immunohistochemistry of pre-shock kidney
biopsies from a previous study in this swine strain showed markedly lower PPAR-β/δ
receptor expression than in healthy animals.
Conclusions: In swine with pre-existing atherosclerosis, the PPAR-β/δ agonist GW0742
failed to attenuate septic shock-induced circulatory failure and kidney dysfunction, most
likely due to reduced receptor expression coinciding with cardiovascular and metabolic
co-morbidity.
Keywords: Kidney function; Neutrophil gelatinase-associated lipocalin; Apoptosis;
Necrosis; Heme oxygenase-1; Oxidative stress; Inducible nitric oxide synthase;
Nitrotyrosine; Nuclear transcription factor κB2013 Wepler et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly cited.
Wepler et al. Intensive Care Medicine Experimental 2013, 1:9 Page 2 of 10
http://www.icm-experimental.com/content/1/1/9Background
Ample evidence is available that the activation of the peroxisome proliferator-activated re-
ceptors (PPAR), ligand-activated transcription factors of the nuclear hormone receptor
family, presenting as PPAR-α, PPAR-γ, and PPAR-β/δ, has beneficial effects in various
shock models. The highly selective synthetic PPAR-β/δ agonist GW0742 [1] blunted
shock-induced organ injury as a result of attenuated inflammation and oxidative and
nitrosative stress and decreased activation of the nuclear transcription factor κB (NF-κB)
[2-8]. These organ-protective properties were also present in animals with obesity [9] and
diabetes [10], most likely as a result of enhanced insulin sensitivity and, consequently, im-
proved glucose utilization [11], as well as attenuated endothelial dysfunction [12]. How-
ever, all these data originate from short-term, un-resuscitated rodent models characterized
by hypotension and low cardiac output. Therefore, we tested the hypothesis whether
GW0742 may attenuate kidney dysfunction during long-term, resuscitated, porcine fecal
peritonitis-induced septic shock [13,14]. Given the beneficial effects of GW0742 on glu-
cose homoeostasis [11] and vascular function [12], we investigated swine with hyperlipid-
emia and ubiquitous atherosclerosis [15].Methods
The University of Ulm Animal Care Committee and the Federal authorities for animal re-
search had approved the experiments, which were performed in adherence to National
Institutes of Health Guidelines on the Use of Laboratory Animals. Twenty-two adult,
castrated, male pigs (age 15 to 30 months, median (interquartile range) body weight of 72
(65 to 81) kg) were used. The pig strain is a cross-breed of Rapacz farm pigs homozygous
for the R84C low-density lipoprotein (LDL) receptor mutation with smaller strains
(‘FBM’), with hypercholesteremia due to an atherogenic diet [15].
Animal preparation
Anesthesia and surgical instrumentation have been described in detail previously [13-15].
Briefly, anesthesia was induced with atropine, propofol, and ketamine to allow endo-
tracheal intubation and was maintained thereafter with pentobarbitone, buprenorphine,
and pancuronium. Ventilator settings were fraction of inspired O2 (FiO2) 0.35, positive
end-expiratory pressure (PEEP) 10 cmH2O, tidal volume 8 mL·kg
−1, respiratory rate 10 to
12 breaths·min−1 adjusted to maintain arterial PCO2 = 35 to 40 mmHg, inspiratory (I)/ex-
piratory (E) ratio 1:1.5, peak airway pressure <40 cmH2O, and modified to I/E ratio 1:1
and PEEP 12 or 15 cmH2O, respectively, if the ratio of arterial O2 partial pressure (PaO2)/
FiO2 is <300 or <200 mmHg [13-15]. The right jugular vein and carotid artery were ex-
posed for the insertion of a central venous catheter sheath and the placement of a
balloon-tipped pulmonary artery catheter to measure central venous (CVP), pulmonary
arterial (MPAP), and pulmonary artery occlusion pressures (PAOP), and a thermistor-
tipped arterial catheter for blood pressure (MAP) recording and transpulmonary single in-
dicator thermodilution-cardiac output (CO) measurement. The right kidney and a femoral
vein were surgically exposed, and a catheter was advanced into the inferior vena cava and
manually guided into a right renal vein under visual control [14,15]. A catheter in the
urinary bladder allowed urine collection. Two tubes were placed through the abdominal
wall for peritonitis induction. Ringer's solution was continuously infused as maintenance
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diac filling pressures during surgery.Experimental protocol
After instrumentation and an 8-hour recovery, baseline data were collected. Thereafter,
the supernatant (3 mL·kg−1) of 1.0 g·kg−1 autologous feces incubated in 500 mL 0.9% sa-
line for 12 h at 38°C was injected into the abdominal cavity via the abdominal drainage
tubes. Hydroxyethyl starch (10 mL∙kg−1∙h−1, 5 mL∙kg−1∙h−1 if CVP or PAOP is >18 mmHg)
allowed maintaining hyperdynamic hemodynamics. If necessary, norepinephrine was in-
fused and titrated to maintain MAP at baseline values (no further increase if the heart rate
is ≥160 min−1 to avoid tachycardia-induced myocardial ischemia) [13-16]. Animals ran-
domly received i.v. GW0742 (0.03 mg∙kg−1, n = 10, body weight 71 (66 to 80) kg) or ve-
hicle (DMSO; n = 12, body weight 75 (66 to 81) kg) at 6, 12, and 18 h after the induction
of peritonitis. The same GW0742 dose attenuated renal dysfunction in murine endotoxic
shock [2] and organ injury after kidney ischemia/reperfusion injury in diabetic rats [10].
The timing of the GW0742 administration was chosen, because10-day survival was dou-
bled in mice injected with this dose at 6.5 and 12.5 h after cecal ligation and puncture-
induced sepsis [2]. After additional data collection at 12 and 24 h after the induction of
peritonitis, animals were sacrificed under deep anesthesia.
Measurements and calculations
Hemodynamics, gas exchange (calorimetric O2 uptake and CO2 production, arterial
and mixed venous blood gases), glucose, lactate, creatinine, renal venous nitrite + ni-
trate (NO2
− + NO3
−), tumor necrosis factor-α (TNFα), and interleukin-6 (IL-6) con-
centrations were determined as described previously [13-16]. Endogenous glucose
production and glucose oxidation were derived from plasma 1,2,3,4,5,6-13C6-glucose
and the mixed expiratory 13CO2 isotope enrichment, respectively, during continuous
glucose isotope infusion [13,14]. Urinary and blood creatinine and Na+ levels were ana-
lyzed to calculate creatinine clearance and fractional Na+-excretion [9] together with
blood neutrophil gelatinase-associated lipocalin (NGAL) [15]. At the end of the experi-
ment, immediate post-mortem kidney tissue samples were analyzed for the expression
of the inducible nitric oxide synthase (iNOS), heme oxygenase-1 (HO-1), and cleaved
caspase-3 as well as for the activation of the nuclear transcription factor κB (NF-κB) as
described in detail previously [15,16]. Pyramid-shaped kidney specimens showing kid-
ney cortex, medulla, renal papilla, and the corresponding renal calyx were dissected for
histopathological examination, performed by an experienced pathologist (A.S.) blinded
for the sample grouping [15]. Histopathological alterations were analyzed for the degree
of ‘glomerular tubularization’, dilatation of Bowman's space, and swelling of Bowman's
capsule, cellular edema of the proximal tubule, distal tubular dilatation and elongation,
tubular protein cylinders, and tubular necrosis as described in detail previously [15].
Immunohistochemistry allowed quantifying the formation of nitrotyrosine (rabbit anti-
Nitrotyrosine, Millipore, Schwalbach, Germany) [16] and the expression of the PPAR-β/δ
(rabbit anti-PPAR delta antibody #ab23673, Abcam plc, Cambridge, UK), the method be-
ing described in detail in the supplement. The latter was determined on formalin-fixed,
paraffin-embedded kidney biopsies, which had been taken during surgical instrumentation
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as age-matched FBM pigs that had not been fed with the atherogenic diet (n = 5 in each
group). Results are presented as mean densitometric sum red.
Statistical analysis
Data are presented as median (quartiles). After the exclusion of normal distribution using
the Kolmogorov-Smirnoff test, differences within groups were analyzed by a Friedmann
analysis of variance on ranks and a subsequent Dunn's test with Bonferroni correction.
Inter-group differences were tested using a Mann–Whitney rank sum test.Results
One animal in the control group died 15 h after the induction of peritonitis; therefore, data
at the end of the experiment originate from 11 vehicle-treated animals only. Colloid and
norepinephrine requirements were comparable in the two groups (Additional file 1: Table
A). MAP progressively decreased and CO increased despite aggressive circulatory support,
ultimately resulting in impaired pulmonary gas exchange and lactic acidosis, however, with-
out inter-group difference (Table 1). Sepsis caused a progressive deterioration of renal func-
tion, coinciding with increased renal venous concentrations of pro-inflammatory cytokines,
NO metabolites, and isoprostanes, again without any inter-group difference (Table 2).
Western blotting confirmed the findings on blood biomarkers, while tissue expression of
HO-1, iNOS, and activated caspase 3 were comparable to those from animals that had
undergone surgical instrumentation only, sepsis nearly tripled NF-κB activation (Additional
file 1: Table B). There was, however, no treatment effect.
Kidney histopathology showed only mild to moderate glomerular and tubular damage
without inter-group difference (Additional file 1: Table C). Immunohistochemistry showed
marked nitrotyrosine formation, again without inter-group difference (Additional file 1:
Table B). Immunohistochemistry of the renal PPAR-β/δ showed that expression was
nearly ten times lower than both in young and healthy German Landswine and age-
matched FBM pigs that had not been fed with the atherogenic diet (Figure 1).
Discussion
This study was to test the hypothesis whether the PPAR-β/δ agonist GW0742 would at-
tenuate kidney injury during long-term, resuscitated, polymicrobial porcine septic
shock. Since GW0742 had been effective in animals with obesity and diabetes, we stud-
ied swine with hyperlipidemia and ubiquitous atherosclerosis [15]. The major findings
were that (1) GW0742 failed to attenuate sepsis-induced organ dysfunction and histo-
logical damage and (2) did not affect the parameters of inflammation and oxidative and
nitrosative stress.
The lacking efficacy of GW0742 is in contrast to previous studies in polymicrobial
sepsis [2,7], which, however, report data from young and otherwise healthy rodents.
We studied septic shock in FBM swine, a strain presenting with ubiquitous
hypercholesteremia-induced atherosclerosis [15]. In addition, these animals showed a
several-fold reduction of the kidney PPAR-β/δ expression as compared to young and
healthy German Landswine. In obese, insulin-resistant mice, weight loss increased
PPAR-γ expression [17], and both starvation and endurance training activated PPAR-δ







Body temperature (°C) DMSO 36.5 (35.7, 37.4) 37.6 (37.0, 38.4)a 38.4 (37.5, 38.7)a
GW0742 36.9 (36.5, 37.3) 38.1 (37.7, 38.2)a 38.0 (37.7, 38.3)a
Heart rate (min−1) DMSO 83 (70, 99) 144 (121, 149)a 149 (142, 163)a
GW0742 69 (63, 92) 134 (126, 146)a 158 (150, 162)a
Mean arterial pressure (mmHg) DMSO 103 (92, 108) 90 (87, 101)a 75 (65, 98)a
GW0742 110 (106, 114) 97 (93, 100)a 83 (75, 94)a
Mean pulmonary artery pressure (mmHg) DMSO 25 (22, 26) 38 (28, 42)a 39 (35, 40)a
GW0742 27 (24, 27) 35 (34, 38)a 42 (38, 47)a
Central venous pressure (mmHg) DMSO 13 (9, 14) 15 (12, 17)a 18 (17, 18)a
GW0742 13 (11, 15) 15 (13, 17)a 19 (17, 22)a
Pulmonary artery occluded pressure (mmHg) DMSO 13 (10, 14) 15 (14, 17)a 17 (17, 19)a
GW0742 15 (11, 17) 16 (14, 18)a 17 (16, 20)a
Cardiac output (L·min−1) DMSO 4.4 (3.8, 5.2) 6.4 (5.7, 7.9)a 8.0 (5.7, 9.3)a
GW0742 4.4 (3.7, 5.2) 7.1 (6.1, 8.5)a 7.6 (7.1, 7.8)a
Hemoglobin (g·L−1) DMSO 94 (80, 100) 111 (99, 123)a 115 (110, 121)a
GW0742 91 (80, 102) 104 (107, 119)a 110 (107, 119)a
Arterial PO2 (mmHg) DMSO 176 (161, 185) 151 (121, 161) 118 (91, 144)
a
GW0742 180 (171, 181) 163 (125, 172) 118 (110, 139)a
PaO2/FiO2 ratio (mmHg) DMSO 550 (502, 583) 459 (362, 503)
a 244 (109, 398)a
GW0742 536 (487, 611) 470 (392, 574)a 236 (205, 386)a
Arterial PCO2 (mmHg) DMSO 36 (34, 38) 38 (37, 41) 37 (35, 40)
GW0742 35 (33, 37) 38 (38, 39) 36 (34, 38)
Arterial pH DMSO 7.45 (7.44, 7.46) 7.45 (7.39, 7.46) 7.35 (7.22, 7.41)a
GW0742 7.45 (7.43, 7.46) 7.45 (7.40, 7.47) 7.36 (7.29, 7.41)a
Arterial base excess (mmol·L−1) DMSO 1.2 (−0.3, 1.7) 1.7 (−1.1, 4.3) −4.3 (−11.7, −0.8)a
GW0742 0.4 (−0.5, 0.6) 2.5 (0.5, 4.0) −5.3 (−7.7, −1.6)a
Arterial lactate (mmol·L−1) DMSO 0.8 (0.7, 1.4) 1.0 (0.8, 2.0) 4.1 (1.7, 8.3)a
GW0742 1.1 (0.9, 1.3) 1.0 (.7, 1.4) 2.6 (2.4, 4.5)a
O2 uptake (mL·kg
−1·min−1) DMSO 2.5 (2.2, 2.9) 3.0 (2.7, 3.1) 4.1 (3.5, 4.3)a
GW0742 2.6 (2.5, 2.9) 2.7 (2.3, 3.5) 3.8 (3.4, 4.6)a
CO2 production (mL·kg
−1·min−1) DMSO 2.4 (2.2, 2.7) 2.8 (2.5, 3.0) 3.2 (3.1, 3.6)a
GW0742 2.3 (2.0, 2.6) 2.6 (2.4, 3.0) 3.2 (2.8, 3.6)a
Blood glucose (mg·dL) DMSO 118 (109, 127) 76 (64, 88)a 94 (73, 120)
GW0742 117 (111, 122) 68 (58, 73)a 75 (69, 83)a
Glucose production (mg·kg−1·min−1] DMSO 1.3 (1.3, 1.5) 2.1 (2.0, 2.5) 3.0 (2.4, 3.3)
GW0742 1.3 (1.2, 1.8) 2.3 (2.1, 2.8) 3.0 (2.8, 3.5)
Glucose oxidation (mg·kg−1·min−1) DMSO 0.4 (0.3, 0.4) 1.3 (1.2, 1.4) 1.7 (1.6, 2.1)
GW0742 0.3 (0.3, 0.4) 1.4 (1.3, 1.6) 1.9 (1.6, 2.3)
All data are presented as median (quartiles); vehicle (DMSO): n = 12 (n = 11 during 12- to 24-h peritonitis), GW0742:
n = 10; ap < 0.05 vs. before peritonitis.
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β/δ activation normalized the diabetes-related endothelial dysfunction [12]. Our FBM
swine presented with both hypercholesteremia as well as impaired glucose homoeostasis;
Table 2 Parameters of renal O2 exchange, metabolism, function (NGAL - neutrophil
gelatinase-associated lipocalin), as well as renal venous biomarkers of inflammation
(NO2
− + NO3







Renal venous PO2 (mmHg) DMSO 54 (45, 61) 60 (50, 61) 56 (47, 61)
GW0742 53 (47, 55) 58 (52, 63) 56 (48, 60)
Renal venous PCO2 (mmHg) DMSO 40 (38, 41) 44 (41, 45) 45 (41, 47)
GW0742 38 (36, 40) 44 (42, 45) 42 (37, 46)
Renal venous pH DMSO 7.42 (7.41, 7.44) 7.42 (7.36, 7.44) 7.30 (7.12, 7.39)a
GW0742 7.43 (7.40, 7.45) 7.42 (7.38, 7.44) 7.31 (7.23, 7.40)a
Renal venous base excess (mmol1·L−1) DMSO 1.4 (0.0, 2.5) 2.4 (−0.2, 4.7) −4.4 (−12.3, 1.5)a
GW0742 1.0 (0.1, 1.7) 3.3 (1.3, 4.4) −4.7 (−8.2, -2.1)a
Renal venous lactate (mmol1·L−1) DMSO 0.9 (0.7, 1.4) 1.0 (0.9, 1.9) 4.1 (1.3, 9.2)a
GW0742 1.0 (0.7, 1.0) 1.3 (1.2, 1.5) 3.2 (2.1, 4.3)a
Arterial creatinine (μmol1·L−1) DMSO 90 (84, 96) 81 (75, 96) 126 (98, 141)a
GW0742 93 (87, 95) 81 (80, 88) 124 (94, 137)a
Blood NGAL (ng·L−1) DMSO 65 (55, 72) n.d. 364 (270, 400)a
GW0742 56 (53, 61) n.d. 365 (276, 400)a
Urine output (mL·kg−1·h−1) DMSO 8.8 (7.7, 10.4) 3.2 (1.8, 5.1)a
GW0742 10.0 (8.2, 10.7) 3.6 (2.4, 6.7)a
Creatinine clearance (mL1·min−1) DMSO 120 (91, 134) 56 (39, 96)a
GW0742 129 (114, 140) 78 (66, 81)a
Fractional Na+ excretion (%) DMSO 10 (8, 11) 5 (4, 8)a
GW0742 8 (7, 9) 4 (3, 4)a
Renal venous interleukin-6 (ng·L−1) DMSO 96 (77, 139) 1,710 (1,242, 4,807)a 8,405 (2,565, 23,153)a
GW0742 97 (77, 107) 2,656 (1,186, 2,910)a 3,457 (3,348, 3,489)a
Renal venous tumor necrosis
factor-α (ng·L−1)
DMSO 34 (28, 52) 70 (55, 105)a 125 (91, 172)a
GW0742 49 (42, 126) 63 (50, 84)a 183 (131, 239)a
Renal venous NO2
− + NO3
− (μmol·L−1) DMSO 7 (5, 14) 10 (8, 15) 14 (12, 21)a
GW0742 9 (6, 10) 9 (8, 14) 17 (10, 21)a
Renal venous 8-isoprostane (ng·L−1) DMSO 85 (80, 131) 96 (78, 132) 123 (90, 166)a
GW0742 83 (72, 109) 91 (70, 113) 123 (87, 264)a
Data on urine output, creatinine clearance, and fractional Na+ excretion refer to 0 to 12 and 12 to 24 h of peritonitis,
respectively. All data are presented as median (quartiles); vehicle (DMSO): n = 12 (n = 11 at 24-h peritonitis), GW0742:
n = 10; ap < 0.05 vs. before peritonitis.
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of glucose production) when compared to young (age 3 to 4 months) and healthy German
Landswine undergoing the same protocol of resuscitated fecal peritonitis [13,14]. Hence,
the pre-existing atherosclerosis together with the ‘metabolic syndrome’ may have caused
GW0742 inefficacy due to PPAR-β/δ down-regulation. It could be argued in this context
that GW0742 did attenuate ischemia/reperfusion injury in obese and diabetic rats [9,10].
These data, however, originate from un-resuscitated, short-term models in rats, whereas
we studied long-term, fully resuscitated porcine septic shock.
Our findings of reduced PPAR-β/δ expression were obtained from biopsies taken during
surgical instrumentation, i.e., prior to any inflammatory challenge [15]. Since the abdominal
cavity had been closed again after the surgical instrumentation, we could not obtain kidney
Figure 1 Examples and results of the quantitative image analysis of the PPAR-β/δ immunohisto-
chemistry in biopsies. Examples (A) (magnification ×20; left panel: German Landswine, right panel: FBM
swine) and results of the quantitative image analysis (B) of the PPAR-β/δ immunohistochemistry in biopsies
taken during surgical instrumentation in comparison to biopsies taken in otherwise young and healthy German
Landswine undergoing a similar surgical instrumentation. German Landswine (open box-and-whisker plots),
FBM swine with (dark gray box-and-whisker plots), and without hyperchloesteremic diet (light gray box-and-
whisker plots). All data are median (quartiles, range; n = 5 in each group).
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gravated PPAR-β/δ down-regulation and thus contributed to the lacking efficacy of
GW0742. In rodents, any shock-related effect on PPAR expression seems to be organ-
specific; hemorrhage, injection of endotoxin, or cecal ligation and puncture significantly
reduced pulmonary [20], myocardial [21], and hepatic [22] PPAR-α, -γ, or -δ protein ex-
pression and/or mRNA. However, endotoxemia only decreased renal PPAR-α mRNA,
whereas PPAR-γ and PPAR-δ mRNA remained unchanged [23].Limitations of the study
Since we did not study the effect of GW0742 in young and healthy animals, we do not
have direct evidence that the PPAR-β/δ down-regulation associated with the underlying
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contributed to our findings, e.g., the use of adult swine per se, the integration of standard
intensive care procedures into the experimental design, the timing and dosing of the treat-
ment, and/or the duration of the study. To our knowledge, GW0742 has only been stud-
ied in rodents. Nevertheless, GW501516, another highly specific PPAR-β/δ agonist with a
chemical structure very close to that of GW0742 [1], attenuated endotoxin-induced
NF-κB activation, and cytokine release not only in rodent [24-26] but also in human tis-
sues [26,27]. So far, a modulation of the PPAR-β/δ expression related to nutritional and/or
metabolic interventions has only been studied in rodents as well [18,19]. However, in
swine, a similar diet-induced hypercholesteremia as in our experiments [28] was associ-
ated with a markedly reduced PPAR-α and PPAR-γ expression [29], coinciding with
impaired glucose tolerance [28,29], arterial hypertension [28], increased transaminase ac-
tivities [29], and aggravated oxidative stress [28]. Treatment with resveratrol restored
PPAR-α and PPAR-γ expression [29], going along with improved left heart perfusion and
function during chronic myocardial ischemia [30,31]. It could be argued that all rodent
data on GW0742 were obtained in young animals, while we studied adult swine. In fact, is-
chemia/reperfusion injury and hemorrhagic shock induced PPAR-γ expression only in
young but not in adult or old rodents [32,33], which in turn impaired adaptive autophagy
[33]. There are no data available on PPAR-β/δ expression under these conditions, but the
above-mentioned studies on hypercholesteremia-induced PPAR-α and PPAR-γ down-
regulation also originate from adult swine. Moreover, tissue PPAR-β/δ expression in kidneys
from adult FBM swine that had not been fed with cholesterol-enriched diet was similar to
that in young and healthy German Landswine (Figure 1B). We only studied the effect of
0.03 mg∙kg−1 of GW0742. This dose was chosen because it attenuated kidney dysfunction
in murine endotoxin- and cecal ligation and puncture-induced septic shock at plasma con-
centrations selectively activating the PPAR-β/δ without any cross-reactivity on the other
PPAR isoforms [2]. Moreover, in rats, this dose reduced organ injury after kidney ischemia/
reperfusion injury [10], and a ten times higher dose did not further influence myocardial is-
chemia/reperfusion injury [3]. It should be noted in this context that equipotent drug doses
are usually much lower on a per kilogram basis in large species (e.g., swine, dogs) than in ro-
dents [34]. FBM swine present with reduced creatinine clearance and moderate histological
damage of the kidney already under baseline conditions [15]. Nevertheless, any pre-existing
organ dysfunction most likely did not influence our results; due to fluid resuscitation and cat-
echolamine infusion, creatinine clearance was comparable to that in young and healthy
German Landswine undergoing the same protocol of resuscitated fecal peritonitis [13,14].Conclusions
In swine with pre-existing atherosclerosis, the PPAR-β/δ agonist GW0742 failed to attenu-
ate septic shock-induced kidney dysfunction and organ damage, most likely due to re-
duced receptor expression associated with cardiovascular and metabolic co-morbidity.
Additional file
Additional file 1: Supplementary information. Table A: Norepinephrine infusion rate, hydroxyethyl starch infusion
rate and urine output. Table B: Activation of NF-κB, protein expression of the iNOS, HO-1, cleaved caspase-3, and
nitrotyrosine in post mortem kidney specimen. Table C: Kidney histopathology score. Figure A: Representative examples
of the histopathological items analyzed.
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